Authors:
GUEBREXABIER M
SHANNON EJ
KAZEN R
KEBRET Z
FROMME D
Citation: M. Guebrexabier et al., EARLY DETECTION OF RIFAMPIN IN HUMAN NERVE-TISSUE AFTER AN ORAL DOSE OF 600 MILLIGRAMS, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1866-1870
Authors:
SHANNON EJ
FROMMEL D
GUEBREXABIER M
HAILEMARIAM HS
Citation: Ej. Shannon et al., TITRATION OF NUMBERS OF HUMAN-DERIVED MYCOBACTERIUM-LEPRAE REQUIRED TO PROGRESSIVELY OXIDIZE C-14 PALMITIC ACID AND RELEASE CO-14(2), Leprosy review, 65(2), 1994, pp. 100-105
Citation: Hs. Habtemariam et M. Guebrexabier, LOSS OF VIABILITY OF MYCOBACTERIUM-LEPRAE ISOLATED FROM NASAL SECRETIONS OF LEPROMATOUS LEPROSY PATIENTS FOLLOWING DAILY RIFAMPICIN AND DDSTHERAPY, Leprosy review, 64(4), 1993, pp. 312-315
Citation: H. Habtemariam et M. Guebrexabier, LACK OF RESPONSE TO WHO MDT - A CASE-REPORT, International journal of leprosy and other mycobacterial diseases, 61(4), 1993, pp. 632-634
Authors:
GUEBREXABIER M
NURILIGN A
GEBREHIWOT A
HAILU A
SISSAY Y
GETACHEW E
FROMMEL D
Citation: M. Guebrexabier et al., SEROEPIDEMIOLOGIC SURVEY OF TOXOPLASMA-GONDII INFECTION IN ETHIOPIA, Ethiopian medical journal, 31(3), 1993, pp. 201-208